Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections
Postoperative pancreatic fistula is the most common severe complication after pancreatic surgery. It associated with increased morbidity and prolonged hospital stay. Identifying patients at low risk for postoperative pancreatic fistula is essential to enable timely removal of drains and facilitate e...
Gespeichert in:
| Veröffentlicht in: | Surgery 2024-12, Vol.176 (6), p.1732-1738 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1738 |
|---|---|
| container_issue | 6 |
| container_start_page | 1732 |
| container_title | Surgery |
| container_volume | 176 |
| creator | Aghamaliyev, Ughur Cepele, Ganildo Hofmann, Felix O. Knoblauch, Mathilda Kessler, Claudius Crispin, Alexander Weniger, Maximilian Andrassy, Joachim Renz, Bernhard W. Werner, Jens |
| description | Postoperative pancreatic fistula is the most common severe complication after pancreatic surgery. It associated with increased morbidity and prolonged hospital stay. Identifying patients at low risk for postoperative pancreatic fistula is essential to enable timely removal of drains and facilitate early discharge. Although postoperative hyperamylasemia is linked to postoperative pancreatic fistula, the role of postoperative hyperlipasemia remains unclear. This study aims to investigate the role of postoperative hyperlipasemia in predicting postoperative pancreatic fistula B/C pancreaticoduodenectomy and distal pancreatectomy.
The study included 471 patients who underwent pancreaticoduodenectomy and distal pancreatectomy at our institution between January 1, 2019, and February 28, 2023. Postoperative hyperamylasemia and postoperative hyperlipasemia were defined as values above the upper limit of normal established at our institution.
In univariate analysis, postoperative hyperlipasemia and postoperative hyperamylasemia on postoperative day 0 demonstrated the strongest association with postoperative pancreatic fistula B/C. Consequently, a subset of 177 patients with available serum lipase and amylase data underwent further investigation. Besides body mass index and high-risk pathology, both postoperative hyperlipasemia and postoperative hyperamylasemia on postoperative day 0 emerged as independent risk factors for postoperative pancreatic fistula B/C in univariate analysis. In multivariate analysis, postoperative hyperlipasemia on postoperative day 0 emerged as a significant predictor of postoperative pancreatic fistula B/C, with body mass index as independent risk factor of postoperative pancreatic fistula B/C.
The absence of postoperative hyperlipasemia on postoperative day 0 could potentially serve as an effective diagnostic tool for identifying patients who are at a low risk of developing postoperative pancreatic fistula B/C after pancreaticoduodenectomy and distal pancreatectomy. Consequently, not only serum amylase, but also serum lipase can be integrated into clinical practice alongside other relevant parameters. |
| doi_str_mv | 10.1016/j.surg.2024.09.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3114150875</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039606024007001</els_id><sourcerecordid>3114150875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c237t-87aa97cf19ddfbfafb57eb2821b84807c2290fbed24cc71f02c2531a59a61d0c3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVJ6G6T_oEego-52B1JlmVBLyG03UAgl-QsZHnUavFXJDmQ_vpo2bSUHHIaDe8zL-gh5AuFigJtvu6ruIZfFQNWV6AqAPGBbKngrJS8oSdkC8BV2UADG_Ipxj0AqJq2H8mGKy4FNGJL_uyeFwyDX0zE0ZvCT0X6jYUfR-y9SVgsc0xzRkzyT3nD4Oe-WEJObYpvUzPZgPltC-djWgdTGJcw_B8EjGiTn6d4Tk6dGSJ-fp1n5OHH9_vrXXl79_Pm-uq2tIzLVLbSGCWto6rvXeeM64TEjrWMdm3dgrSMKXAd9qy2VlIHzDLBqRHKNLQHy8_I5bF3CfPjijHp0UeLw2AmnNeoOaU1FdBKkVF2RG2YYwzo9BL8aMKzpqAPzvVeH5zrg3MNSmfn-ejitX_tsrV_J38lZ-DbEcD8yyePQUfrcbLZYcgudD_79_pfAA8el2M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3114150875</pqid></control><display><type>article</type><title>Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Aghamaliyev, Ughur ; Cepele, Ganildo ; Hofmann, Felix O. ; Knoblauch, Mathilda ; Kessler, Claudius ; Crispin, Alexander ; Weniger, Maximilian ; Andrassy, Joachim ; Renz, Bernhard W. ; Werner, Jens</creator><creatorcontrib>Aghamaliyev, Ughur ; Cepele, Ganildo ; Hofmann, Felix O. ; Knoblauch, Mathilda ; Kessler, Claudius ; Crispin, Alexander ; Weniger, Maximilian ; Andrassy, Joachim ; Renz, Bernhard W. ; Werner, Jens</creatorcontrib><description>Postoperative pancreatic fistula is the most common severe complication after pancreatic surgery. It associated with increased morbidity and prolonged hospital stay. Identifying patients at low risk for postoperative pancreatic fistula is essential to enable timely removal of drains and facilitate early discharge. Although postoperative hyperamylasemia is linked to postoperative pancreatic fistula, the role of postoperative hyperlipasemia remains unclear. This study aims to investigate the role of postoperative hyperlipasemia in predicting postoperative pancreatic fistula B/C pancreaticoduodenectomy and distal pancreatectomy.
The study included 471 patients who underwent pancreaticoduodenectomy and distal pancreatectomy at our institution between January 1, 2019, and February 28, 2023. Postoperative hyperamylasemia and postoperative hyperlipasemia were defined as values above the upper limit of normal established at our institution.
In univariate analysis, postoperative hyperlipasemia and postoperative hyperamylasemia on postoperative day 0 demonstrated the strongest association with postoperative pancreatic fistula B/C. Consequently, a subset of 177 patients with available serum lipase and amylase data underwent further investigation. Besides body mass index and high-risk pathology, both postoperative hyperlipasemia and postoperative hyperamylasemia on postoperative day 0 emerged as independent risk factors for postoperative pancreatic fistula B/C in univariate analysis. In multivariate analysis, postoperative hyperlipasemia on postoperative day 0 emerged as a significant predictor of postoperative pancreatic fistula B/C, with body mass index as independent risk factor of postoperative pancreatic fistula B/C.
The absence of postoperative hyperlipasemia on postoperative day 0 could potentially serve as an effective diagnostic tool for identifying patients who are at a low risk of developing postoperative pancreatic fistula B/C after pancreaticoduodenectomy and distal pancreatectomy. Consequently, not only serum amylase, but also serum lipase can be integrated into clinical practice alongside other relevant parameters.</description><identifier>ISSN: 0039-6060</identifier><identifier>ISSN: 1532-7361</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1016/j.surg.2024.09.005</identifier><identifier>PMID: 39375065</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Amylases - blood ; Female ; Humans ; Hyperamylasemia - blood ; Hyperamylasemia - diagnosis ; Hyperamylasemia - epidemiology ; Hyperamylasemia - etiology ; Hyperlipidemias - blood ; Lipase - blood ; Male ; Middle Aged ; Pancreatectomy - adverse effects ; Pancreatic Fistula - diagnosis ; Pancreatic Fistula - epidemiology ; Pancreatic Fistula - etiology ; Pancreaticoduodenectomy - adverse effects ; Postoperative Complications - blood ; Postoperative Complications - diagnosis ; Postoperative Complications - epidemiology ; Postoperative Complications - etiology ; Postoperative Period ; Retrospective Studies ; Risk Factors</subject><ispartof>Surgery, 2024-12, Vol.176 (6), p.1732-1738</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c237t-87aa97cf19ddfbfafb57eb2821b84807c2290fbed24cc71f02c2531a59a61d0c3</cites><orcidid>0000-0002-5178-8358 ; 0000-0001-9574-8051 ; 0000-0003-1110-9346 ; 0009-0007-3866-280X ; 0000-0002-4964-9439 ; 0000-0003-0970-2132</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.surg.2024.09.005$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39375065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aghamaliyev, Ughur</creatorcontrib><creatorcontrib>Cepele, Ganildo</creatorcontrib><creatorcontrib>Hofmann, Felix O.</creatorcontrib><creatorcontrib>Knoblauch, Mathilda</creatorcontrib><creatorcontrib>Kessler, Claudius</creatorcontrib><creatorcontrib>Crispin, Alexander</creatorcontrib><creatorcontrib>Weniger, Maximilian</creatorcontrib><creatorcontrib>Andrassy, Joachim</creatorcontrib><creatorcontrib>Renz, Bernhard W.</creatorcontrib><creatorcontrib>Werner, Jens</creatorcontrib><title>Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections</title><title>Surgery</title><addtitle>Surgery</addtitle><description>Postoperative pancreatic fistula is the most common severe complication after pancreatic surgery. It associated with increased morbidity and prolonged hospital stay. Identifying patients at low risk for postoperative pancreatic fistula is essential to enable timely removal of drains and facilitate early discharge. Although postoperative hyperamylasemia is linked to postoperative pancreatic fistula, the role of postoperative hyperlipasemia remains unclear. This study aims to investigate the role of postoperative hyperlipasemia in predicting postoperative pancreatic fistula B/C pancreaticoduodenectomy and distal pancreatectomy.
The study included 471 patients who underwent pancreaticoduodenectomy and distal pancreatectomy at our institution between January 1, 2019, and February 28, 2023. Postoperative hyperamylasemia and postoperative hyperlipasemia were defined as values above the upper limit of normal established at our institution.
In univariate analysis, postoperative hyperlipasemia and postoperative hyperamylasemia on postoperative day 0 demonstrated the strongest association with postoperative pancreatic fistula B/C. Consequently, a subset of 177 patients with available serum lipase and amylase data underwent further investigation. Besides body mass index and high-risk pathology, both postoperative hyperlipasemia and postoperative hyperamylasemia on postoperative day 0 emerged as independent risk factors for postoperative pancreatic fistula B/C in univariate analysis. In multivariate analysis, postoperative hyperlipasemia on postoperative day 0 emerged as a significant predictor of postoperative pancreatic fistula B/C, with body mass index as independent risk factor of postoperative pancreatic fistula B/C.
The absence of postoperative hyperlipasemia on postoperative day 0 could potentially serve as an effective diagnostic tool for identifying patients who are at a low risk of developing postoperative pancreatic fistula B/C after pancreaticoduodenectomy and distal pancreatectomy. Consequently, not only serum amylase, but also serum lipase can be integrated into clinical practice alongside other relevant parameters.</description><subject>Adult</subject><subject>Aged</subject><subject>Amylases - blood</subject><subject>Female</subject><subject>Humans</subject><subject>Hyperamylasemia - blood</subject><subject>Hyperamylasemia - diagnosis</subject><subject>Hyperamylasemia - epidemiology</subject><subject>Hyperamylasemia - etiology</subject><subject>Hyperlipidemias - blood</subject><subject>Lipase - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pancreatectomy - adverse effects</subject><subject>Pancreatic Fistula - diagnosis</subject><subject>Pancreatic Fistula - epidemiology</subject><subject>Pancreatic Fistula - etiology</subject><subject>Pancreaticoduodenectomy - adverse effects</subject><subject>Postoperative Complications - blood</subject><subject>Postoperative Complications - diagnosis</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Period</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><issn>0039-6060</issn><issn>1532-7361</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVJ6G6T_oEego-52B1JlmVBLyG03UAgl-QsZHnUavFXJDmQ_vpo2bSUHHIaDe8zL-gh5AuFigJtvu6ruIZfFQNWV6AqAPGBbKngrJS8oSdkC8BV2UADG_Ipxj0AqJq2H8mGKy4FNGJL_uyeFwyDX0zE0ZvCT0X6jYUfR-y9SVgsc0xzRkzyT3nD4Oe-WEJObYpvUzPZgPltC-djWgdTGJcw_B8EjGiTn6d4Tk6dGSJ-fp1n5OHH9_vrXXl79_Pm-uq2tIzLVLbSGCWto6rvXeeM64TEjrWMdm3dgrSMKXAd9qy2VlIHzDLBqRHKNLQHy8_I5bF3CfPjijHp0UeLw2AmnNeoOaU1FdBKkVF2RG2YYwzo9BL8aMKzpqAPzvVeH5zrg3MNSmfn-ejitX_tsrV_J38lZ-DbEcD8yyePQUfrcbLZYcgudD_79_pfAA8el2M</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Aghamaliyev, Ughur</creator><creator>Cepele, Ganildo</creator><creator>Hofmann, Felix O.</creator><creator>Knoblauch, Mathilda</creator><creator>Kessler, Claudius</creator><creator>Crispin, Alexander</creator><creator>Weniger, Maximilian</creator><creator>Andrassy, Joachim</creator><creator>Renz, Bernhard W.</creator><creator>Werner, Jens</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5178-8358</orcidid><orcidid>https://orcid.org/0000-0001-9574-8051</orcidid><orcidid>https://orcid.org/0000-0003-1110-9346</orcidid><orcidid>https://orcid.org/0009-0007-3866-280X</orcidid><orcidid>https://orcid.org/0000-0002-4964-9439</orcidid><orcidid>https://orcid.org/0000-0003-0970-2132</orcidid></search><sort><creationdate>202412</creationdate><title>Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections</title><author>Aghamaliyev, Ughur ; Cepele, Ganildo ; Hofmann, Felix O. ; Knoblauch, Mathilda ; Kessler, Claudius ; Crispin, Alexander ; Weniger, Maximilian ; Andrassy, Joachim ; Renz, Bernhard W. ; Werner, Jens</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c237t-87aa97cf19ddfbfafb57eb2821b84807c2290fbed24cc71f02c2531a59a61d0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Amylases - blood</topic><topic>Female</topic><topic>Humans</topic><topic>Hyperamylasemia - blood</topic><topic>Hyperamylasemia - diagnosis</topic><topic>Hyperamylasemia - epidemiology</topic><topic>Hyperamylasemia - etiology</topic><topic>Hyperlipidemias - blood</topic><topic>Lipase - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pancreatectomy - adverse effects</topic><topic>Pancreatic Fistula - diagnosis</topic><topic>Pancreatic Fistula - epidemiology</topic><topic>Pancreatic Fistula - etiology</topic><topic>Pancreaticoduodenectomy - adverse effects</topic><topic>Postoperative Complications - blood</topic><topic>Postoperative Complications - diagnosis</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Period</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aghamaliyev, Ughur</creatorcontrib><creatorcontrib>Cepele, Ganildo</creatorcontrib><creatorcontrib>Hofmann, Felix O.</creatorcontrib><creatorcontrib>Knoblauch, Mathilda</creatorcontrib><creatorcontrib>Kessler, Claudius</creatorcontrib><creatorcontrib>Crispin, Alexander</creatorcontrib><creatorcontrib>Weniger, Maximilian</creatorcontrib><creatorcontrib>Andrassy, Joachim</creatorcontrib><creatorcontrib>Renz, Bernhard W.</creatorcontrib><creatorcontrib>Werner, Jens</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aghamaliyev, Ughur</au><au>Cepele, Ganildo</au><au>Hofmann, Felix O.</au><au>Knoblauch, Mathilda</au><au>Kessler, Claudius</au><au>Crispin, Alexander</au><au>Weniger, Maximilian</au><au>Andrassy, Joachim</au><au>Renz, Bernhard W.</au><au>Werner, Jens</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2024-12</date><risdate>2024</risdate><volume>176</volume><issue>6</issue><spage>1732</spage><epage>1738</epage><pages>1732-1738</pages><issn>0039-6060</issn><issn>1532-7361</issn><eissn>1532-7361</eissn><abstract>Postoperative pancreatic fistula is the most common severe complication after pancreatic surgery. It associated with increased morbidity and prolonged hospital stay. Identifying patients at low risk for postoperative pancreatic fistula is essential to enable timely removal of drains and facilitate early discharge. Although postoperative hyperamylasemia is linked to postoperative pancreatic fistula, the role of postoperative hyperlipasemia remains unclear. This study aims to investigate the role of postoperative hyperlipasemia in predicting postoperative pancreatic fistula B/C pancreaticoduodenectomy and distal pancreatectomy.
The study included 471 patients who underwent pancreaticoduodenectomy and distal pancreatectomy at our institution between January 1, 2019, and February 28, 2023. Postoperative hyperamylasemia and postoperative hyperlipasemia were defined as values above the upper limit of normal established at our institution.
In univariate analysis, postoperative hyperlipasemia and postoperative hyperamylasemia on postoperative day 0 demonstrated the strongest association with postoperative pancreatic fistula B/C. Consequently, a subset of 177 patients with available serum lipase and amylase data underwent further investigation. Besides body mass index and high-risk pathology, both postoperative hyperlipasemia and postoperative hyperamylasemia on postoperative day 0 emerged as independent risk factors for postoperative pancreatic fistula B/C in univariate analysis. In multivariate analysis, postoperative hyperlipasemia on postoperative day 0 emerged as a significant predictor of postoperative pancreatic fistula B/C, with body mass index as independent risk factor of postoperative pancreatic fistula B/C.
The absence of postoperative hyperlipasemia on postoperative day 0 could potentially serve as an effective diagnostic tool for identifying patients who are at a low risk of developing postoperative pancreatic fistula B/C after pancreaticoduodenectomy and distal pancreatectomy. Consequently, not only serum amylase, but also serum lipase can be integrated into clinical practice alongside other relevant parameters.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39375065</pmid><doi>10.1016/j.surg.2024.09.005</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-5178-8358</orcidid><orcidid>https://orcid.org/0000-0001-9574-8051</orcidid><orcidid>https://orcid.org/0000-0003-1110-9346</orcidid><orcidid>https://orcid.org/0009-0007-3866-280X</orcidid><orcidid>https://orcid.org/0000-0002-4964-9439</orcidid><orcidid>https://orcid.org/0000-0003-0970-2132</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0039-6060 |
| ispartof | Surgery, 2024-12, Vol.176 (6), p.1732-1738 |
| issn | 0039-6060 1532-7361 1532-7361 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3114150875 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Aged Amylases - blood Female Humans Hyperamylasemia - blood Hyperamylasemia - diagnosis Hyperamylasemia - epidemiology Hyperamylasemia - etiology Hyperlipidemias - blood Lipase - blood Male Middle Aged Pancreatectomy - adverse effects Pancreatic Fistula - diagnosis Pancreatic Fistula - epidemiology Pancreatic Fistula - etiology Pancreaticoduodenectomy - adverse effects Postoperative Complications - blood Postoperative Complications - diagnosis Postoperative Complications - epidemiology Postoperative Complications - etiology Postoperative Period Retrospective Studies Risk Factors |
| title | Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A38%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperlipasemia%20in%20the%20immediate%20postoperative%20period%20predicts%20postoperative%20pancreatic%20fistula%20after%20pancreatic%20resections&rft.jtitle=Surgery&rft.au=Aghamaliyev,%20Ughur&rft.date=2024-12&rft.volume=176&rft.issue=6&rft.spage=1732&rft.epage=1738&rft.pages=1732-1738&rft.issn=0039-6060&rft.eissn=1532-7361&rft_id=info:doi/10.1016/j.surg.2024.09.005&rft_dat=%3Cproquest_cross%3E3114150875%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3114150875&rft_id=info:pmid/39375065&rft_els_id=S0039606024007001&rfr_iscdi=true |